• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by OptimizeRx Corporation

< Previous 1 2 Next >
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
July 17, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
June 24, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
May 16, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
May 12, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
May 01, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
April 23, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
April 18, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
March 12, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
March 11, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
March 10, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
February 27, 2025
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
December 23, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
November 18, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Third Quarter 2024 Financial Results
November 13, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
October 31, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
September 10, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
September 09, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Second Quarter 2024 Financial Results
August 08, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
July 25, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
July 23, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
July 15, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
June 20, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports First Quarter 2024 Financial Results
May 14, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
May 06, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
April 26, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
April 16, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
April 11, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
March 25, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
March 11, 2024
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
< Previous 1 2 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap